Chan, J. F., Zhu, Z., Chu, H., Yuan, S., Chik, K. K., Chan, C. C., . . . Yuen, K. (2018). The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res.
Chicago Stili AlıntıChan, Jasper Fuk-Woo, et al. "The Celecoxib Derivative Kinase Inhibitor AR-12 (OSU-03012) Inhibits Zika Virus Via Down-regulation of the PI3K/Akt Pathway and Protects Zika Virus-infected A129 Mice: A Host-targeting Treatment Strategy." Antiviral Res 2018.
MLA AlıntıChan, Jasper Fuk-Woo, et al. "The Celecoxib Derivative Kinase Inhibitor AR-12 (OSU-03012) Inhibits Zika Virus Via Down-regulation of the PI3K/Akt Pathway and Protects Zika Virus-infected A129 Mice: A Host-targeting Treatment Strategy." Antiviral Res 2018.